Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Epidosin
2. N,n-diethyl-n-methyl-2-(3-methyl-2-phenylvaleryloxy)ethylammonium Bromide
3. Valethamate Bromide
1. Valethamate Ion
2. Valethamate Cation
3. 16376-74-2
4. D64s64qvx7
5. Murel
6. N,n-diethyl-n-methyl-2-(3-methyl-2-phenylvaleryloxy)ethylammonium
7. Ethanaminium, N,n-diethyl-n-methyl-2-((3-methyl-1-oxo-2-phenylpentyl)oxy)-
8. N,n-diethyl-n-methyl-2-((3-methyl-1-oxo-2-phenylpentyl)oxy)ethanaminium
9. Epidosan
10. Ncgc00185757-01
11. Unii-d64s64qvx7
12. Letamate
13. Velamate
14. Elist
15. Release V
16. Valethamate [who-dd]
17. Schembl249537
18. Chembl2111176
19. Dtxsid40859155
20. Chebi:135303
21. Diethyl-methyl-[2-(3-methyl-2-phenylpentanoyl)oxyethyl]azanium
22. Db13497
23. Q27276155
24. Diethyl-methyl-[2-(3-methyl-2-phenyl-pentanoyl)oxyethyl]ammonium
25. N,n-diethyl-n-methyl-2-[(3-methyl-2-phenylpentanoyl)oxy]ethan-1-aminium
26. Ammonium, Diethyl(2-hydroxyethyl)methyl-, 3-methyl-2-phenylvalerate (ester) (8ci)
27. Ethanaminium, N,n-diethyl-n-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]-, Bromide
| Molecular Weight | 306.5 g/mol |
|---|---|
| Molecular Formula | C19H32NO2+ |
| XLogP3 | 4.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 10 |
| Exact Mass | 306.243304264 g/mol |
| Monoisotopic Mass | 306.243304264 g/mol |
| Topological Polar Surface Area | 26.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 1 |
| Complexity | 319 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AX - Other drugs for functional gastrointestinal disorders
A03AX14 - Valethamate
ABOUT THIS PAGE
A Valethamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valethamate, including repackagers and relabelers. The FDA regulates Valethamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valethamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valethamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valethamate supplier is an individual or a company that provides Valethamate active pharmaceutical ingredient (API) or Valethamate finished formulations upon request. The Valethamate suppliers may include Valethamate API manufacturers, exporters, distributors and traders.
click here to find a list of Valethamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Valethamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Valethamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Valethamate GMP manufacturer or Valethamate GMP API supplier for your needs.
A Valethamate CoA (Certificate of Analysis) is a formal document that attests to Valethamate's compliance with Valethamate specifications and serves as a tool for batch-level quality control.
Valethamate CoA mostly includes findings from lab analyses of a specific batch. For each Valethamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Valethamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Valethamate EP), Valethamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valethamate USP).
LOOKING FOR A SUPPLIER?
